Robles Ricardo, Marín Caridad, Abellán Beatriz, López Asunción, Pastor Patricia, Parrilla Pascual
Department of Surgery, Virgen de la Arrixaca University Hospital, Murcia, Spain.
Surg Endosc. 2008 Nov;22(11):2357-64. doi: 10.1007/s00464-008-9770-x. Epub 2008 Mar 6.
The best type of laparoscopic approach in solid liver tumours (SLTs), whether total laparoscopic surgery or hand-assisted laparoscopic surgery (HALS), has not yet been established. Our objective is to present our experience with laparoscopic liver resections in SLTs performed by HALS using a new approach.
We performed 35 laparoscopic resections in SLTs, of which 26 were carried out using HALS (in 25 patients) and 21 patients had liver metastases of a colorectal origin (LMCRC) (1 patient had 2 resections), 1 metastasis from a neuroendocrine tumour of the pancreas, 1 hepatocarcinoma on a healthy liver, 1 primary hepatic leiomyosarcoma and 1 giant haemangioma. Mean follow-up was 22 months. OPERATION: One right hemihepatectomy, one left hemihepatectomy, five bisegmentectomies II-III, three bisegmentectomies VI-VII and 16 segmentectomies (five of S. VI, three of S. VIII; three of S. V; two of S. IVb; one of S. II; one of S. IV; and in the remaining case resection of S. III and VI plus resection of a metastasis in S. VIII).
Morbidity and mortality, conversion to open procedure, intraoperative blood loss, intra- and postoperative transfusion, length of stay and survival.
There were no intra- or postoperative deaths, nor were there any conversions. One patient presented with morbidity (3.8%) (liver abscess). Mean blood loss was 200 ml (range 0-600 ml). One patient required transfusion (3.8%). Mean operative time was 180 min (range 120-360 min). Mean length of hospital stay was 4 days (range 2-5 days). The actuarial survival rate of the patients at 36 months with liver metastases from colorectal carcinoma (LMCRC) was 80%.
Liver resection with HALS reproduces the low morbidity and mortality rates and effectiveness (3-year survival) of open surgery in SLTs when indicated selectively.
对于实体肝肿瘤(SLTs),最佳的腹腔镜手术方式,无论是完全腹腔镜手术还是手辅助腹腔镜手术(HALS),尚未确定。我们的目的是介绍我们采用新方法通过HALS进行腹腔镜肝切除治疗SLTs的经验。
我们对35例SLTs患者进行了腹腔镜肝切除术,其中26例采用HALS(25例患者),21例患者有结直肠癌肝转移(LMCRC)(1例患者接受了2次切除),1例胰腺神经内分泌肿瘤转移,1例健康肝脏上的肝癌,1例原发性肝平滑肌肉瘤和1例巨大血管瘤。平均随访时间为22个月。手术:1例右半肝切除术,1例左半肝切除术,5例II-III段双段切除术,3例VI-VII段双段切除术和16例肝段切除术(S. VI段5例,S. VIII段3例;S. V段3例;S. IVb段2例;S. II段1例;S. IV段1例;在其余病例中切除S. III和VI段并切除S. VIII段的转移灶)。
发病率和死亡率、转为开放手术、术中失血、术中及术后输血、住院时间和生存率。
术中及术后均无死亡病例,也无转为开放手术者。1例患者出现并发症(3.8%)(肝脓肿)。平均失血量为200 ml(范围0-600 ml)。1例患者需要输血(3.8%)。平均手术时间为180分钟(范围120-360分钟)。平均住院时间为4天(范围2-5天)。结直肠癌肝转移(LMCRC)患者36个月时的精算生存率为80%。
选择性应用时,HALS肝切除术在SLTs中可重现开放手术的低发病率、低死亡率和有效性(3年生存率)。